Literature DB >> 12182119

Modeling the effects of genetic factors on late-onset diseases in cohort studies.

Mark E Glickman1, David R Gagnon.   

Abstract

Many late-onset diseases are caused by what appears to be a combination of a genetic predisposition to disease and environmental factors. The use of existing cohort studies provides an opportunity to infer genetic predisposition to disease on a representative sample of a study population, now that many such studies are gathering genetic information on the participants. One feature to using existing cohorts is that subjects may be censored due to death prior to genetic sampling, thereby adding a layer of complexity to the analysis. We develop a statistical framework to infer parameters of a latent variables model for disease onset. The latent variables model describes the role of genetic and modifiable risk factors on the onset ages of multiple diseases, and accounts for right-censoring of disease onset ages. The framework also allows for missing genetic information by inferring a subject's unknown genotype through appropriately incorporated covariate information. The model is applied to data gathered in the Framingham Heart Study for measuring the effect of different Apo-E genotypes on the occurrence of various cardiovascular disease events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182119     DOI: 10.1023/a:1015880003274

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  22 in total

1.  Regression with frailty in survival analysis.

Authors:  C A McGilchrist; C W Aisbett
Journal:  Biometrics       Date:  1991-06       Impact factor: 2.571

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

Authors:  D Blacker; J L Haines; L Rodes; H Terwedow; R C Go; L E Harrell; R T Perry; S S Bassett; G Chase; D Meyers; M S Albert; R Tanzi
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

5.  Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.

Authors:  P W Wilson; R H Myers; M G Larson; J M Ordovas; P A Wolf; E J Schaefer
Journal:  JAMA       Date:  1994-12-07       Impact factor: 56.272

6.  Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians.

Authors:  J Louhija; H E Miettinen; K Kontula; M J Tikkanen; T A Miettinen; R S Tilvis
Journal:  Arterioscler Thromb       Date:  1994-07

7.  Estimation of morbid risk and age at onset with missing information.

Authors:  L A Cupples; N Risch; L A Farrer; R H Myers
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

8.  Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease.

Authors:  J E Eichner; L H Kuller; T J Orchard; G A Grandits; L M McCallum; R E Ferrell; J D Neaton
Journal:  Am J Cardiol       Date:  1993-01-15       Impact factor: 2.778

9.  Genetic associations with human longevity at the APOE and ACE loci.

Authors:  F Schächter; L Faure-Delanef; F Guénot; H Rouger; P Froguel; L Lesueur-Ginot; D Cohen
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

10.  Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?

Authors:  N T Lautenschlager; L A Cupples; V S Rao; S A Auerbach; R Becker; J Burke; H Chui; R Duara; E J Foley; S L Glatt; R C Green; R Jones; H Karlinsky; W A Kukull; A Kurz; E B Larson; K Martelli; A D Sadovnick; L Volicer; S C Waring; J H Growdon; L A Farrer
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more
  2 in total

1.  Assessing pneumonia identification from time-ordered narrative reports.

Authors:  Cosmin A Bejan; Lucy Vanderwende; Mark M Wurfel; Meliha Yetisgen-Yildiz
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

2.  Full likelihood analysis of genetic risk with variable age at onset disease--combining population-based registry data and demographic information.

Authors:  Janne Pitkäniemi; Sirkka-Liisa Varvio; Jukka Corander; Nella Lehti; Jukka Partanen; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Andrew Thomas; Elja Arjas
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.